Limit Bleeding Risk in Patients Who Need an Anticoagulant Plus Antiplatelets
Debate continues about how to manage patients on an anticoagulant (warfarin, etc) who also need antiplatelets (aspirin, etc).
Many patients end up on "triple antithrombotic therapy"...such as warfarin for atrial fib PLUS clopidogrel and aspirin after a stent.
But bleeding risk is high. One in 50 patients will have a serious bleed in the first month of triple therapy...and 1 in 8 in the first year.